Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers.
Rago, Florencia
Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers. [electronic resource] - Biochemical and biophysical research communications 01 2019 - 109-116 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2018.09.009 doi
Animals
Antineoplastic Agents--administration & dosage
CRISPR-Cas Systems
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Line, Tumor
DNA Helicases--genetics
Female
Gene Knockout Techniques
Humans
Isoquinolines--administration & dosage
Lung Neoplasms--drug therapy
Mice
Mice, Nude
Mutation
Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors
Nuclear Proteins--genetics
Oxidative Phosphorylation--drug effects
Proteolysis
Sulfonamides--administration & dosage
Transcription Factors--antagonists & inhibitors
Xenograft Model Antitumor Assays
Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers. [electronic resource] - Biochemical and biophysical research communications 01 2019 - 109-116 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2018.09.009 doi
Animals
Antineoplastic Agents--administration & dosage
CRISPR-Cas Systems
Carcinoma, Non-Small-Cell Lung--drug therapy
Cell Line, Tumor
DNA Helicases--genetics
Female
Gene Knockout Techniques
Humans
Isoquinolines--administration & dosage
Lung Neoplasms--drug therapy
Mice
Mice, Nude
Mutation
Myeloid Cell Leukemia Sequence 1 Protein--antagonists & inhibitors
Nuclear Proteins--genetics
Oxidative Phosphorylation--drug effects
Proteolysis
Sulfonamides--administration & dosage
Transcription Factors--antagonists & inhibitors
Xenograft Model Antitumor Assays